Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-016405
Filing Date
2025-02-07
Accepted
2025-02-07 16:58:32
Documents
5
Effectiveness Date
2025-02-07

Document Format Files

Seq Description Document Type Size
1 S-8 tnya_2025_s-8.htm S-8 188762
2 EX-5.1 tnya-ex5_1.htm EX-5.1 15557
3 EX-23.1 tnya-ex23_1.htm EX-23.1 4885
4 EX-FILING FEES tnya-exfiling_fees.htm EX-FILING FEES 42932
5 GRAPHIC img208693244_0.jpg GRAPHIC 3633
  Complete submission text file 0000950170-25-016405.txt   258373
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

EIN.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-284784 | Film No.: 25602688
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)